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ABSTRACT
The homeobox transcription factor CDX2 plays a
crucial role in intestinal cell fate specification, both
during normal development and in tumorigenic
processes involving intestinal reprogramming. The
CDX2 regulatory network is intricate, but it has not
yet been fully uncovered. Through genome-wide
screening of a 3D culture system, the RNA-binding
protein MEX3A was identified as putatively involved
in CDX2 regulation; therefore, its biological rele-
vance was addressed by setting up cell-based
assays together with expression studies in murine
intestine. We demonstrate here that MEX3A has a
repressive function by controlling CDX2 levels in
gastric and colorectal cellular models. This is
dependent on the interaction with a specific
binding determinant present in CDX2 mRNA
30untranslated region. We have further determined
that MEX3A impairs intestinal differentiation and
cellular polarization, affects cell cycle progression
and promotes increased expression of intestinal
stem cell markers, namely LGR5, BMI1 and MSI1.
Finally, we show that MEX3A is expressed in
mouse intestine, supporting an in vivo context for
interaction with CDX2 and modulation of stem cell
properties. Therefore, we describe a novel CDX2
post-transcriptional regulatory mechanism,
through the RNA-binding protein MEX3A, with a
major impact in intestinal differentiation, polarity
and stemness, likely contributing to intestinal
homeostasis and carcinogenesis.
INTRODUCTION
The homeodomain transcription factor CDX2 is a critical
determinant of intestinal homeostasis, both during devel-
opment and throughout adult life. CDX2 is involved in
the antero-posterior patterning of the mammalian embryo
and is the key molecular mediator of intestinal differenti-
ation (1–4). Furthermore, multiple evidences substantiate
CDX2 crucial role in carcinogenesis of the digestive tract.
It was shown to inhibit cell growth and migration in vitro
as well as dissemination of colon tumour cells in vivo (5).
CDX2 heterogeneous loss has also been observed in colo-
rectal carcinomas (CRCs), particularly in invasive cells
at the tumour edge (6). Moreover, CDX2 reduction
increases the progression of chemically induced CRCs
(7). Conversely, under certain pathological conditions,
CDX2 becomes abnormally expressed in other organs of
the digestive tract besides intestine, namely the esophagus
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(8) and stomach (9,10), driving a precancerous lesion
known as intestinal metaplasia, a process conﬁrmed in
transgenic mouse models (11,12).
Owing to the essential function in intestinal develop-
ment, differentiation and carcinogenesis, CDX2 regula-
tion has been extensively studied. We have previously
identiﬁed different mechanisms involved in the tran-
scriptional regulation of this gene such as the Bone
morphogenetic protein (BMP) pathway (13), SOX2 (14)
and a CDX2 autoregulatory loop (15). Several transcrip-
tion factors including HNF4a, GATA6, TCF4 and
b-catenin were shown to interact with Cdx2 promoter
fragments (16). However, mutations at the CDX2 locus
are a rare event in CRC (17), and its expression does
not depend on methylation of the proximal promoter
(18). On the other hand, CDX2 protein phosphorylation
has also been shown to modify its activity in intestinal
cells (19,20). These and other studies support the notion
that CDX2 regulation is intricate and strictly controlled.
During the past two decades, post-transcriptional regu-
lation emerged as a fundamental mechanism guiding gene
expression in higher eukaryotic cells, being at the core of
normal cellular processes but also cancer initiation and
development. It is now increasingly clear that RNAmatur-
ation, localization, translation and stability provide
multiple layers of spatio-temporal control determining a
transcript’s fate (21,22). These coupled events are generally
dependent on the cooperation between cis-regulatory
elements and trans-acting factors, such as non-coding
RNAs and RNA-binding proteins (RBPs). RBPs have
been implicated in virtually every aspect of RNA metabol-
ism (22,23), particularly, their repressive role is critical to
establish precise translational patterns that deﬁne develop-
mental and differentiation switches in many organisms.
In Caenorhabditis elegans, MEX-3 is a translational
repressor that regulates blastomere identity during early
embryogenesis (24) and germline totipotency in the adult
worm (25). MEX-3 has two K homology domains, which
are conserved single-stranded RNA-binding motifs (26).
Mutations disrupting mex-3 locus are lethal, resulting in
embryos that inappropriately generate body-wall muscle
from the anterior blastomere; hence, the name mex for
‘muscle excess’. This is speciﬁed, in part, by the repressive
function that MEX-3 exerts over the transcription factor
pal-1, the C. elegans orthologue of caudal in Drosophila
and CDX in mammals (24,27). In humans, mex-3 was
identiﬁed and characterized as four homologous genes,
MEX3A–D (28,29), whose biological relevance is starting
to be explored. Recently, the functional role of MEX3C
as a RNA-binding ubiquitin E3 ligase was established,
mediating the post-transcriptional decay of HLA-A
allotypes (30). It was also shown to be necessary for
normal postnatal growth in mutant mice by enhancing
the local expression of insulin-like growth factor 1 in
bone (31) and appears to be involved in metabolic regu-
lation of energy balance (32), through yet unknown
effectors. A variant form of MEX3D called TINO was
shown to negatively regulate the antiapoptotic protein
BCL-2 in HeLa cells (33). Finally, knockdown of
MEX3A by siRNAs was shown to suppress cell prolifer-
ation and migration in human gastric cancer cells, but the
molecular mechanisms behind these ﬁndings were not ad-
dressed (34). Pursuing the aim of uncovering new CDX2
regulatory mechanisms, we explored a putative transla-
tional repression by MEX3A, which was inversely
correlated with CDX2 in a 3D experimental model. By
studying MEX3A expression in vivo and using a cell
line-based approach to modulate its levels in vitro, our
study describes a novel post-transcriptional process by
which CDX2 expression is impaired in the gastrointestinal
setting and intestinal-like homeostasis compromised,
through alterations in differentiation, polarity and
stemness features. Another layer of control is thus added
to the complex CDX2 regulatory network, involving
MEX3A as a key regulator of intestinal homeostasis,
which might have signiﬁcant implications to gastrointes-
tinal carcinogenesis.
MATERIALS AND METHODS
Cell culture and treatments
Human gastric carcinoma cell line AGS (ATCC,
American Type Culture Collection) and CRC cell line
Caco-2 (ATCC) were cultured under standard conditions
in RPMI-1640 medium and Dulbecco’s modiﬁed Eagle’s
medium, respectively, containing 10% fetal bovine serum,
100 U/ml of penicillin and 100 mg/ml of streptomycin (Life
Technologies). For the AGS 3D culture, ﬂasks were
coated with 50 ml/cm2 of matrigel basement membrane
(BD Biosciences) at a 1.5:1 proportion to serum-free
medium. A 2 104 cells/cm2 suspension was seeded on
top and maintained for 14 days with medium change
every 2 days. For the Caco-2 3D culture, coverslips were
coated with 60 ml/cm2 of matrigel. A 6 103 cells/cm2
suspension plus 2% matrigel was seeded on top and main-
tained for 8 days with medium change every 2 days.
To quantify lumen formation, >100 cysts were microscop-
ically examined. For proteasome inhibition, cells were
treated with 25 mM MG132 (Calbiochem) or vehicle
treated with DMSO. To inhibit transcription, cells were
exposed to 10 mg/ml of Actinomycin D (Sigma).
Constructs and site-directed mutagenesis
The previously published pCMV-MEX3A expression
vector (28) was used together with a pCMV-Tag3B
empty vector (Agilent Technologies) in transfections.
A pRLControl construct containing a humanized Renilla
luciferase (Rluc) coding sequence (35) was used as a
backbone to create the pRLCDX2 vector, encoding a
luciferase fusion transcript to the parental CDX2
30untranslated region (UTR). The QuickChange site-
directed mutagenesis kit (Stratagene) was then used to
introduce speciﬁc mutations in the previous plasmid, to
generate the pRLCDX2 construct, with a mutated
MEX-3 recognition element (MRE). Oligonucleotides
containing the desired mutations were designed according
to the manufacturer’s instructions (Supplementary Table
S1). Taking into account the degenerate consensus
sequence described for MEX-3 binding in C. elegans, a
mutational background of Cytidine was used because pre-
sumably this base is not tolerated in the MRE (36).
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Transfections, RNAi and luciferase assays
Transient transfections were done using Lipofectamine
2000 reagent according to the manufacturer’s guidelines
(Life Technologies). A DNA (mg) to Lipofectamine 2000
reagent (ml) ratio of 1:1.5 in OPTI-MEM medium was
used for routine transfection experiments of expression
vectors. For stable transfections, selection was initiated
48 h post-transfection in medium supplemented with
0.6mg/ml of G418 (Sigma). Neomycin-resistant positive
clones obtained through limiting dilution were routinely
maintained with 0.2mg/ml of G418. A commercial set of
three Stealth Select siRNA duplexes (HSS150674,
HSS150675 and HSS150676) directed against human
MEX3A (Life Technologies) and a custom set of three
siRNA duplexes directed against CDX2 were used with
scrambled controls. An siRNA duplexes (pmol) to
Lipofectamine 2000 reagent (ml) ratio of 20:1 in OPTI-
MEM medium was used for inhibition experiments.
Luciferase reporter assays were performed with the Rluc
Assay System (Promega), and b-galactosidase activity was
used for normalization of experimental variations.
RNA isolation and quantitative real-time PCR
Total RNA was extracted using TRI Reagent (Sigma) and
reverse transcribed using the Superscript II Reverse
Transcriptase kit (Life Technologies). Analysis of BMI1,
CDX2, GAPDH, LGR5, MEX3A and Rluc mRNA
expression was performed in an ABI Prism 7500 system
using SYBRgreen reagent (Life Technologies) and speciﬁc
primer pairs (Supplementary Table S1). Each sample was
ampliﬁed in triplicate and speciﬁcity conﬁrmed by dissoci-
ation analysis. The 18S rRNA expression was measured
for normalization of target gene abundance.
Microarrays and data processing
Experiments were performed at the National Facility for
DNA Microarrays (Aveiro, Portugal). Three independent
2D and 3D AGS cell cultures were selected for total RNA
extraction using TRI Reagent. RNA quantity and quality
were assessed using the Nanodrop ND-1000 (Thermo
Scientiﬁc) and 2100 Bioanalyzer (Agilent Technologies)
systems, and only samples with a RNA integrity number
above nine were considered for further study. Preparation
and labelling of the RNA was performed using the
One-Color Microarray-Based Gene Expression Analysis
Quick Amp Labelling kit (Agilent Technologies). Brieﬂy,
600 ng of total RNA from 2D and 3D biological replicas
was used as input together with spike-in controls to
generate Cyanine 3-labelled cRNA. The ampliﬁed cRNA
samples were puriﬁed with RNeasy Mini kit (Qiagen) and
hybridized to Human Gene expression 4 44K v2
Microarray slides (Agilent Technologies) at 65C for
17 h. After washing procedures, images of the hybridiza-
tions were acquired using a G2505B Microarray Scanner
(Agilent Technologies). The Feature Extraction software
was used for spot identiﬁcation, background subtraction
and quantiﬁcation of the ﬂuorescent signal. Raw expres-
sion data were processed using BRB-ArrayTools v3.8.1
software (37). After base 2 log transformation and
average of probe replicates, normalization was applied
using the median intensity over the entire array to
minimize systematic variance. Differentially expressed
transcripts between the two culture conditions were
ﬁltered using the Class Comparison tool, performing an
unpaired sample t-test with a P< 0.01 and considering a
minimal 1.5-fold change. Hierarchical clustering analysis
of signiﬁcantly altered genes was conducted in TIGR
MultiExperiment Viewer v4.8.1 software (38) using
Euclidean correlation and average linkage clustering, and
expression values indicated colorimetrically. Functional
annotation of differentially expressed genes, identiﬁed by
extending the unpaired t-test parameter to P< 0.05 and
maintaining the minimal fold change was performed
with DAVID program (39). Microarray data have been
submitted to the ArrayExpress database (http://www.ebi.
ac.uk/arrayexpress/) and assigned the identiﬁer E-MTAB-
1234. The complete list of differentially expressed genes is
detailed in Supplementary Table S2.
Protein extraction and western blot analysis
Cells were lysed for 30 min on ice in a lysis buffer
containing 20mM Tris–HCl (pH 7.5), 150mM NaCl,
2mM ethylenediaminetetraacetic acid and 1% IGEPAL
(Sigma), supplemented with Complete protease inhibitor
cocktail (Roche Applied Science), 1mM PMSF and 1mM
Na3VO4. Lysates were centrifuged at 12 000 rpm for 20
min at 4C and the supernatant recovered. Protein con-
centration was determined using the BCA Protein Assay
Reagent (Thermo Scientiﬁc). Protein extracts (30–50 mg)
were run on 10% sodium dodecyl sulphate–polyacryl-
amide gel electrophoresis, transferred to a nitrocellulose
membrane, blotted overnight with appropriate antibodies
(Supplementary Table S1), and signals revealed with
ECL detection kit (GE Healthcare Life Sciences). Actin
levels were used to normalize protein expression, and
quantiﬁcation of western blots was performed using Fiji
software (40).
Flow cytometry
Caco-2 cells were harvested 48 h after transfection at con-
ﬂuence and ﬁxed with 1% paraformaldehyde for 20 min
at room temperature followed by permeabilization with
0.1% Triton X-100 (Sigma) for 5 min on ice. Staining
was performed with anti-MEX3A antibody and visualized
with goat anti-rabbit FITC-conjugated secondary
antibody. For DNA content assessment, cells were
incubated with a propidium iodide (50 mg/ml) and
RNAse A (200 mg/ml) solution (Sigma) for 30 min at
room temperature. Samples were read in a FACSCanto
II (BD Biosciences) ﬂow cytometer, and analysis was
performed using the FlowJo software.
RNA-immunoprecipitation assay
Cells were lysed 48 h after transfection as indicated for
protein extraction but with the addition of 20 U/ml of
RNAseOUT Ribonuclease inhibitor (Life Technologies).
Before the lysis procedure, cells were washed with phos-
phate buffered saline (PBS) and subjected to ultraviolet
crosslink (254-nm wavelength) at an energy level
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of 1.8 J/cm2 on ice for 20 min. Immunoprecipitation
from protein extracts (750 mg) was performed overnight
with anti-myc antibody (Clontech) or normal mouse
immunoglobulin G (IgG) (Millipore) and RNA-
immunocomplexes recovered by incubation with protein
G-sepharose bead slurry (Sigma) for 2 h in the following
day. After ﬁve washes in lysis buffer containing
RNAseOUT, RNA was extracted from the bead slurry
as indicated before and resuspended in 10 ml of dH2O.
RT-quantitative real-time PCR (qPCR) analysis was
directly performed on the RNA as described. Target
mRNA levels immunoprecipitated in the MEX3A trans-
fected cells were normalized to the levels recovered in the
empty vector transfected cells.
Immunoﬂuorescence and microscopy
Cells grown on coverslips were ﬁxed using ice-cold
methanol for 10 min. For Caco-2 3D assay, cysts were
ﬁxed with a 2% paraformaldehyde and 0.05% glutar-
aldehyde solution at room temperature for 20 min,
followed by quenching with 0.1% NaBH4 and permeabil-
ization with 0.5% Triton X-100. Parafﬁn-embedded
wild-type murine tissue sections (4mm) were deparafﬁnized
with clear-rite (Thermo Scientiﬁc) and rehydrated. All
samples were blocked with non-immune serum diluted in
10% BSA–PBS, followed by incubation with appropriate
antibodies (Supplementary Table S1) diluted in 5% BSA–
PBS. Nuclei were counterstained with 40,6-diamidino-
2-phenylindole (DAPI, Sigma), and coverslips mounted
on microscope slides with Vectashield (Vector). Imaging
acquisition was based on optical sectioning and adjusted
for brightness and contrast with Fiji software (40). Imaging
was performed on an Axio Imager Z1 (Zeiss) Fluorescence
microscope with an ApoTome attachment (Figures 3, 7
and 8 and Supplementary Figure S4), and on a TCS
SP5 II (Leica) Laser Scanning Confocal microscope
(Supplementary Figure S1). The middle focal plane of
Z-stack images with similar total number of planes were
used for representation of cysts polarity.
Statistics
Each experiment was carried out in triplicates at least
three times, and data were expressed as means±SD.
Statistical analysis was performed using Student’s t-test.
A P< 0.05 was considered as signiﬁcantly different.
RESULTS
CDX2 expression is downregulated in AGS cells
cultured in matrigel
In an effort to study CDX2 regulation in a physiologically
relevant microenvironment, we compared CDX2
Figure 1. Establishment of AGS 3D cultures and characterization of CDX2 expression. (A) Schematic representation of the culture systems and
cellular morphology at culture day 4 in bright ﬁeld microscopy (original magniﬁcation, 100). (B) Western blot and qPCR of CDX2 expression in
2D and 3D after 2 weeks culture. Cardinal numbers represent biological replicates. Values for CDX2 mRNA expression in 2D culture were referred
to as 1. (C) Western blot of CDX2 protein expression on treatment with MG132. (D) qPCR of CDX2 mRNA expression on treatment with
actinomycin D. Expression levels in the absence of treatment were set at 100%. Depicted half lives were calculated using exponential regression
(**P=0.003).
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expression in AGS cells cultured in a standard 2D condi-
tion versus a 3D condition with matrigel. Cells depicted
distinct growth patterns amongst both settings, forming a
compact monolayer and conspicuous multicellular aggre-
gates, respectively (Figure 1A). Although there was a
dramatic decrease in CDX2 protein levels in the 3D
culture, mRNA showed heterogeneous levels without cor-
relation with protein (Figure 1B). Treating cells with the
proteasome inhibitor MG132 indicated that CDX2
downregulation was not related to an increase in
proteasome-dependent degradation (Figure 1C). On the
other hand, we found a signiﬁcant difference in CDX2
mRNA stability after actinomycin D treatment to
inhibit transcription (Figure 1D). The CDX2 mRNA
half-life value was higher for the 2D culture
(166.9±15.5 min) than for the 3D culture (62.9±22.1
min). These results suggest the existence of a post-
transcriptional regulatory mechanism, probably acting
over CDX2 mRNA.
With the objective of pinpointing the mechanism
underlying CDX2 downregulation, we performed a
whole-genome expression array, comparing the transcrip-
tome of AGS cells in the two culture conditions. Among
the 340 differentially expressed transcripts, a 1.7-fold
upregulation ofMEX3A was observed in the 3D condition
(Figure 2A and Supplementary Table S2). Additionally,
functional annotation analysis showed alterations related
to fundamental cellular processes like proliferation, differ-
entiation and survival, namely an increase in cell cycle
elements, Notch and Wnt pathways and a decrease in
MAPK and Jak-STAT signalling in the 3D model
(Figure 2B). An increase in RhoGTPases and integrin
signalling was also registered, supporting the occurrence
of increased cell-matrix interactions. Changes in metabolic
patterns were evident by an increase in amino acid biosyn-
thesis (Figure 2B). MEX3A is one of the human ortho-
logues of MEX-3, an RBP with translational inhibitory
function known to target the CDX orthologue pal-1
during C. elegans embryonic development. A novel inter-
action between human MEX3A and CDX2 in a gastro-
intestinal context could constitute a plausible explanation
for the reduction of CDX2 protein levels observed in 3D
culture. Accordingly,MEX3A expression was validated by
qPCR (Figure 2C).
MEX3A overexpression leads to CDX2 downregulation
in AGS cells
To deﬁne whether CDX2 expression is regulated by
MEX3A, AGS cells cultured in standard conditions were
transiently transfected with a myc-tagged MEX3A expres-
sion vector and collected 24 and 48 h later. We showed that
the myc-tagged MEX3A fusion protein was detectable on
transfection and accompanied by a 77 and 64% decrease
in CDX2 protein expression, respectively (Figure 3A).
In contrast, CDX2 mRNA expression did not change
(Figure 3B). This result was conﬁrmed in AGS cells
stably transfected with the myc-tagged MEX3A construct
up until 96 h of culture (Figure 3C and D).
Figure 2. Transcriptome proﬁling of 2D and 3D AGS cultures. (A) Microarray heat map displaying differentially expressed transcripts (P< 0.01,
fold change> 1.5). Values obtained for MEX3A are highlighted. (B) Functional annotation analysis depicting the preponderance of differentially
expressed genes in terms of signaling networks (P< 0.05, fold change> 1.5). (C) qPCR validation of MEX3A expression. Values for MEX3A mRNA
expression in 2D culture were referred to as 1.
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It was previously published that MEX3A and MEX3B
were novel components of P bodies (28,29), discrete cyto-
solic foci characterized in yeast andmammals as centres for
translational silencing and mRNA decay (41). In our
setting, on MEX3A-induced CDX2 protein decrease, we
observed a speciﬁc subcellular localization of MEX3A in P
bodies, as confocal microscopy analysis revealed a partial
overlap between myc-tag staining and two known P body
components, the human mRNA-decapping enzyme 1A
(DCP1A) and the human enhancer of mRNA-decapping
protein 4 (EDC4) (Supplementary Figure S1). Together,
these results demonstrate that MEX3A has the ability to
regulate CDX2 expression at the post-transcriptional level,
probably by interplay with P bodies.
MEX3A interacts with a MRE present in CDX2 30UTR
A bioinformatics search conducted throughout the CDX2
30UTR led to the identiﬁcation of the MEX-3 degenerate
consensus binding sequence (36). The MRE present in
CDX2 mRNA was deﬁned as a bipartite element that
consists of AGAG and UUUA motifs separated by two
Uracil bases (Figure 4A). To assess whether MEX3A
associates with CDX2 30UTR, we preserved RNA–
protein interactions by ultraviolet covalent linkage in
AGS cells transiently transfected with the MEX3A expres-
sion vector and performed an RNA-immunoprecipitation
(RIP) assay. We found a signiﬁcant enrichment in CDX2
mRNA recovered with the anti-myc antibody compared
with control IgG (Figure 4B). On the contrary, no enrich-
ment for GAPDH mRNA was observed (Figure 4B).
Likewise, no enrichment for TBP mRNA and 18S
rRNA was detected (data not shown). Next, we asked
whether MEX3A binds speciﬁcally to the MRE present
within the CDX2 30UTR. To address this question, Rluc
expression vectors containing the wild-type CDX2 30UTR
(pRLCDX2) or the CDX2 30UTR with a mutated MRE
(pRLCDX2) were used in an RIP assay as before
(Figure 4C). A complete loss in MEX3A binding
Figure 3. CDX2 regulation by MEX3A in AGS cells. (A) Western blot of transient transfections with a myc-tagged MEX3A expression vector.
(B) qPCR of CDX2 and MEX3A mRNA expression in the previous samples. The value for CDX2 mRNA expression in the empty vector transfected
cells at 24 h was referred to as 1. (C) Immunoﬂuorescence for MEX3A and CDX2 in MEX3A stably transfected cells at 48 h culture (original
magniﬁcation,400; scale bar 20 mm). (D) Western blot of MEX3A and CDX2 expression in stably transfected cells at different time points.
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capacity was detected when the MRE was mutated, as
observed by comparing the levels of Rluc mRNA re-
covered with anti-myc antibody between the pRLCDX2
and pRLCDX2 transfected cells (Figure 4D).
Additionally, luciferase activity assays proved that the
construct with the mutated MRE was insensitive to
MEX3A function, as a signiﬁcant reduction in Renilla ex-
pression was only detected with the pRLCDX2 transfec-
tion (Figure 4E). We conclude that MEX3A is able to
interact with CDX2 mRNA and that the major determin-
ant for this interaction is a putative MRE located in the
transcript 30UTR.
Intestinal phenotype of Caco-2 cells is affected by
modulating MEX3A levels
To assess the functional consequences of the previous ob-
servations and conﬁrm that they were cell-type independ-
ent, we studied CDX2 regulation by MEX3A in another
model. Caco-2 cell line was chosen for its ability to spon-
taneously differentiate into an enterocytic-like phenotype
on reaching conﬂuence, which has turned it into the most
widely used system to study intestinal cell maturation (42).
Furthermore, this process was previously shown to be
accompanied by an increase in CDX2 protein expression
that, in some established Caco-2 clones, is not explained
by higher transcriptional levels (20). First, we evaluated
the timing of CDX2 and MEX3A expression in Caco-2,
harvesting cells at pre-conﬂuence (day 2), conﬂuence
(day 0) and post-conﬂuence (day 2–8) time points.
Consistent with previous reports, CDX2 protein expres-
sion progressively increased starting from conﬂuence and
during differentiation (Supplementary Figure S2A). This
trend was also veriﬁed at the mRNA level, though not to
the same extent (Supplementary Figure S2B). By contrast,
MEX3A mRNA expression varied in a complementary
manner to that of CDX2, with a decreased expression
associated to more differentiated cells (Supplementary
Figure S2B), although a protein decrease was only
visible at day 8 (Supplementary Figure S2A). We inhibited
endogenous MEX3A using siRNA and observed that
CDX2 protein started to be highly expressed at earlier
time points in cells with downregulated MEX3A expres-
sion (Figure 5A). Paradoxically, this effect was reverted
from conﬂuence onwards, with lower CDX2 protein levels
Figure 4. Mechanistics of MEX3A interaction with CDX2 mRNA in AGS cells. (A) Terminal sequence of CDX2 mRNA, with the predicted MRE
in the 30UTR highlighted in bold and underlined. (B) qPCR showing CDX2 and GAPDH mRNAs immunoprecipitated with myc-tag antibody in
MEX3A transfected cells (*P=0.018). The values for CDX2 and GAPDH mRNA levels in the IgG sample were referred to as 1. (C) Schematic
representation of pRL constructs. (D) qPCR showing Rluc mRNA immunoprecipitated with myc-tag antibody for pRLCDX2 transfection
(****P< 0.0001). Values for Rluc mRNA expression in IgG samples were referred to as 1. (E) Luciferase activity assay for the different pRL
constructs (**P=0.006 for pRLControl/pRLCDX2 and *P=0.036 for pRLCDX2/pRLCDX2). The values obtained for luciferase expression in
the pRLControl co-transfected cells were referred to as 1.
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detected at later time points in cells with MEX3A inhib-
ition (Figure 5A). To evaluate whether this result was
dependent on MEX3A activity or due to transcriptional
regulation, CDX2 mRNA expression was assessed. As
expected, CDX2 mRNA levels were not altered in the
pre-conﬂuence time points but were downregulated from
conﬂuence onwards (Figure 5B), suggesting that after con-
ﬂuence, other MEX3A regulatory functions indirectly
interfere with endogenous CDX2 levels.
It is known that Caco-2 cells acquire expression of dif-
ferent intestinal columnar lineage markers on differenti-
ation, such as Villin. To determine the effect of MEX3A
overexpression in intestinal differentiation, we generated a
Caco-2 cell line stably transfected with the myc-tagged
MEX3A construct. Expression of the myc-tag was con-
ﬁrmed in different conﬂuence states, and a concomitant
reduction in CDX2 protein levels was observed
(Figure 5C). Furthermore, we detected decreased Villin
expression in MEX3A overexpressing cells (Figure 5C).
As differentiation and growth arrest are spatially and tem-
porally related events in the intestinal epithelium, we
studied the expression of cyclin D1, a positive regulator
of proliferation required for cell cycle G1/S transition.
Sustained levels of cyclin D1 were detected in MEX3A
overexpressing cells in latter time points, when the
culture is normally already less proliferative, as observed
by the striking decrease of cyclin D1 in mock cells
(Figure 5C). To ascertain the cell cycle distribution
related to MEX3A overexpression, we transiently trans-
fected near-conﬂuent Caco-2 cells with the myc-tagged
MEX3A construct and performed DNA content analysis
by ﬂow cytometry. Measurements indicated that cells
overexpressing MEX3A possess a different cell cycle
proﬁle (Figure 5D), with a reduced G0/G1 population
(32 against 49% in the empty transfected cells) and an
increased S phase population (41 against 30% in the
empty transfected cells). Given the observed alterations
in differentiation and proliferation parameters, we
Figure 5. MEX3A modulation of intestinal phenotype in Caco-2 cells. (A) Western blot of MEX3A inhibition with transfection of siRNAs per-
formed at day 3 and day 1. (B) qPCR of CDX2 mRNA expression in the same samples. The value for CDX2 at day 2 for the siControl sample
was referred to as 1. (C) Western blot of MEX3A stably transfected cells at different conﬂuences for differentiation and proliferation markers.
(D) Flow cytometry analysis of MEX3A transiently transfected cells. Dot plots depicting negative control (secondary antibody only) and
FITC-conjugated MEX3A expression levels are shown on top. DNA content histograms showing population percentages for the different cell
cycle phases of the empty vector transfected cells and MEX3A-transfected cells (gate MEX3A exogenous) are shown below (*P=0.03 for G0/
G1 phase and *P=0.05 for S phase).
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sought to determine whether MEX3A overexpressing cells
possessed intestinal ‘progenitor or stem-like’ features.
Assessment of expression of well-established intestinal
stem cell markers (43–46) revealed that these cells show
overall increased levels of LGR5, BMI1 and MSI1
(Figure 6), whereas OLFM4 basal expression was barely
detectable and did not change (data not shown).
Importantly, this seems to be independent of CDX2, as
siRNA-mediated CDX2 downregulation did not repro-
duce the increase in MSI1 levels (Figure 6C).
Caco-2 cells retain the ability to polarize and form a
transporting epithelial monolayer in culture (42). This po-
larization process is intimately connected with the forma-
tion of cell–cell contacts and adhesion. In standard culture
conditions, Caco-2 cells overexpressing MEX3A showed
alterations in the distribution of the tight junction marker
ZO-1 compared with the mock cells (Figure 7A). We then
used a 3D cell cyst assay (4) in matrigel to compare the
phenotypic response of both cell lines. We observed that
mock cells developed cyst-like structures in a few days,
with 50% showing a well-deﬁned central lumen
(Figure 7B–D). In contrast, >80% of the MEX3A-
expressing cysts, in which CDX2 reduction and MEX3A
increase was conﬁrmed, failed to elaborate such a lumen
(Figure 7B–D). Additionally, we observed distinct
patterns of E-cadherin and Phalloidin expression. We
detected basolateral E-cadherin expression and accumula-
tion of ﬁlamentous-actin (F-actin) around the hollow
lumen in the mock cysts (Figure 7D), and a reduced
E-cadherin expression in the MEX3A-expressing cysts,
with F-actin appearing ubiquitously distributed (Figure
7D). Thus, we show that the establishment of proper
apical-basal identity is affected on MEX3A
overexpression.
MEX3A is differentially expressed in the crypt-villus unit
To address MEX3A relevance in vivo, we analysed its
presence in mouse normal intestine and compared it
with CDX2 expression. We observed that MEX3A is
expressed in small intestine and colon, exhibiting mainly
a nuclear staining pattern. It shows a stronger expression
in the lower portion of the crypt-villus unit in small intes-
tine and reduced expression in the uppermost part of the
colonic crypts (Figure 8). In the small intestine, CDX2 is
expressed in the same cells as MEX3A except in the base
of the crypts (Figure 8, insert) that exhibit mainly MEX3A
protein. In colon, CDX2 is more expressed in the surface
cells (Figure 8). These results suggest that MEX3A expres-
sion might be important to deﬁne intestinal differentiation
patterns.
DISCUSSION
In this study, we provide the ﬁrst demonstration that
MEX3A represses CDX2 expression in the gastrointes-
tinal context, putatively as a translational repressor, with
direct implications in intestinal differentiation, polarity
and stemness features, key mechanisms for tissue homeo-
stasis that are frequently altered in pathological conditions
and inextricably linked with cancer.
Figure 6. Expression proﬁles of intestinal stem cell markers in Caco-2 cells. (A) qPCR of LGR5 mRNA expression in mock and MEX3A
overexpressing cells. The value for LGR5 at day 3 for the mock sample was referred to as 1. (B) qPCR of BMI1 mRNA expression in the
same samples. The value for BMI1 at day 3 for the mock sample was referred to as 1. (C) Western blot analysis of MSI1 expression in the same
samples and in Caco-2 parental cell line with CDX2 inhibition by siRNAs at the conﬂuence time point.
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3D cell culture systems have been shown to enable
physiological and functional differentiation of several epi-
thelial cell types (47,48), constituting a promising alterna-
tive to overcome standard cell culture limitations.
Accordingly, our transcriptomic analysis performed on a
3D model of AGS cells, which have a signiﬁcant level of
endogenous CDX2 responsive to different molecular
stimuli (13–15), allowed us to disclose MEX3A as a mo-
lecular player involved in the regulation of CDX2 transla-
tion. The array presented an increasedMEX3A expression
in 3D culture and no alteration in the levels of the other
MEX3 family members. We further demonstrated that
MEX3A overexpression leads to marked CDX2 protein
decrease in two cell lines. We tried to overcome the limi-
tation of using overexpression systems by using two dif-
ferent cell lines that were both transiently and stably
transfected with a MEX3A plasmid, which gave concord-
ant results. In addition, CDX2 negative regulation by
MEX3A was conﬁrmed in a more physiological context
using a siRNA approach towards endogenous MEX3A in
Caco-2 cells. We proved that MEX3A is able to interact
with CDX2 mRNA through a canonical MRE present
Figure 7. Polarity alterations induced by MEX3A in Caco-2 cells. (A) Immunoﬂuorescence showing ZO-1 expression in Caco-2 mock and MEX3A
stably transfected cell lines at day 2 of culture (original magniﬁcation,400). (B) Morphology of Caco-2 mock and MEX3A cysts in bright ﬁeld
microscopy during 3D culture (original magniﬁcation, 100) and CDX2/MEX3A expression (original magniﬁcation, 630). (C) Quantiﬁcation of
cysts with lumen or no lumen at culture day 8. (D) Expression of E-cadherin and Phalloidin staining in Caco-2 cysts (original magniﬁcation, 630;
all scale bars 20 mm).
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in the 30UTR. This sequence, which we now show to be
functionally relevant in humans, seems to be the single
determinant of MEX3A binding, independently of the
upstream 50coding region. In fact, bioinformatics
analysis shows that the degenerate MRE motif has been
evolutionarily conserved in different CDX2 homologues
(Supplementary Figure S3), namely in chimpanzee,
mouse, rat, zebraﬁsh, fruit ﬂy and frog, suggesting that
MEX3A is critical for CDX2 regulation.
Endogenously, MEX3A was mainly localized in the
nuclear compartment of intestinal epithelial cells, both
in vitro and in vivo. This result is crucial to show that
a biological background for the regulation of CDX2 by
MEX3A exists. In this regard, a variant form of MEX3D
Figure 8. Expression patterns of MEX3A and CDX2 in mouse normal intestine. Representative immunoﬂuorescence data for MEX3A and CDX2 in
small intestine and colon are shown (original magniﬁcation, 200; scale bars 50 mm; insert original magniﬁcation, 400).
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called TINO, which has been shown to negatively regulate
BCL-2 expression by transcript destabilization, is also pre-
dominantly localized in the nuclei of HeLa cells (33).
On the other hand, MEX3A transfectants showed pre-
dominant cytoplasmic staining. A potential problem
could be antibody speciﬁcity; however, this was success-
fully evaluated by transfection of siRNA duplexes directed
against MEX3A (Supplementary Figure S4). Therefore,
the differential localization in distinct expression
backgrounds might be because a certain threshold in ex-
pression levels has to be achieved for cytoplasmic trans-
location to occur, given that MEX3 proteins are capable
of performing nucleocytoplasmic shuttling (28). On the
other hand, speciﬁc subcellular distribution might be
related with protein phosphorylation, in accordance with
published data describing MEX3 members as phospho-
proteins (28,29). Whichever the case, this does not contra-
dict post-transcriptional regulation, as it can be elicited at
multiple points of the transcript lifespan, including
pre-mRNA processing in the nucleus, export from the
nucleus to the cytoplasm and subsequent coordinated
trafﬁcking of the mature mRNA to the translation ma-
chinery. It also remains to be fully clariﬁed the conse-
quence of partial accumulation in P bodies, structures
involved in processes of mRNA degradation, nonsense-
mediated mRNA decay, translational repression and
RNA-mediated gene silencing (49), although there are
several RBPs with established roles in translational regu-
lation known to colocalize with P bodies (50,51).
We used the Caco-2 cell line model to modulateMEX3A
expression and assess its phenotype. Surprisingly, MEX3A
inhibition produced distinct effects over CDX2 levels de-
pending on cellular conﬂuence. MEX3A might selectively
regulate unique subsets of targets in different culture con-
ditions. In agreement, it is known that transcriptomic and
proteomic changes occur during the progression from the
proliferative state to spontaneous differentiation of Caco-2
cells. Conversely, MEX3A might have a dual role, acting
both as a repressor or enhancer contingent on the cellular
microenvironment, as observed for other RBPs, like HuR
(52). It is possible that intricate associations of MEX3A
with other molecular effectors, namely other proteins or
microRNAs, determine divergent regulatory endings.
MEX3A overexpression in Caco-2 cells resulted in
pronounced phenotypic alterations. CDX2 and Villin
downregulation were indicative of a loss in intestinal dif-
ferentiation, which was further conﬁrmed by the ﬂow
cytometric proﬁle, showing reduced G0/G1 population,
usually associated with less-differentiated cells. Another
hallmark feature of MEX3A overexpression was the
altered cellular polarization in standard culture, as well
as the impaired ability to form polarized structures in the
presence of matrigel. These effects may be mediated by
CDX2, as this transcription factor was previously shown
to regulate intestinal Villin through recruitment of the
Brm-type SWI/SNF complex to its promoter (53), and
MEX3A-expressing cysts closely resemble the ones
obtained with Caco-2 cells in which CDX2 suppression
was achieved by lentiviral short-hairpin RNA particles
(4). It is, therefore, important to ascertain the biological
setting where this regulation might be determinant, which
is suggested by the predominant expression of MEX3A in
the stem, transit-amplifying and migrating post-mitotic
cells of the intestine. Although CDX2 protein can be
detected in most of these cells, its level is lower in the
crypts compared with the uppermost differentiated cells
of the villi (2,19,20). A similar increasing bottom-up
gradient has been described along the colonic gland axis
in the distal colon epithelium. By contrast, in situ hybrid-
ization revealed that CDX2 mRNA was homogeneously
distributed along the entire crypt-villus axis (20). Given
this CDX2 protein expression gradient, that we also
show, and lack of correlation with mRNA, it is likely
that MEX3A ﬁne-tunes CDX2 levels in vivo as well, in a
transcription-independent manner, providing swift avail-
ability of the protein to meet the physiological require-
ments of the continuously renewed gut epithelium.
Moreover, it has been shown that intestinal stem cells
cannot differentiate into any of the intestinal lineages in a
background of Cdx2 ablation (54), revealing the need for
tight CDX2 regulation as determinant to proper phenotype
switching. Most interestingly, we observed higher expres-
sion of different intestinal stem cell markers when we
overexpressed MEX3A in Caco-2, suggesting that this
protein is associated with stem cell features. Our AGS 3D
model also showed a signiﬁcant upregulation of OLFM4
(Supplementary Table S2), previously identiﬁed as a
marker for LGR5+ stem cells in human intestine (46),
although this gene was not directly upregulated in Caco-2
cells, which might be due to intrinsic properties of each cell
line. Strengthening the hypothesis for a role of MEX3A in
stem cell potential, a recent publication showed that
MEX3A is part of the molecular signature of the LGR5+
intestinal stem cells, presenting a 1.64-fold increase in
relation to daughter cells, along with MSI1, LGR5 and
OLFM4 (55). Furthermore, our study reinforces the
increasing knowledge that other regulatory mechanisms
in addition to transcriptional ones have important func-
tions in stem cells. Although we do not know yet how
MEX3A relates with the intestinal stem cell phenotype,
we hypothesize that MEX3A overexpression in itself,
together with the induction of a lessened differentiated
phenotype and polarity defects mediated by CDX2
downregulation, might be critical to allow a permissive en-
vironment for the appearance of stemness features.
Furthermore, theMEX3A–CDX2 axis might be important
during early embryogenesis where CDX2 is required for
correct trophectoderm differentiation, while absent from
the inner cell mass, in a process that requires tight regula-
tion (56). Interestingly, the pattern of expression of the C.
elegans orthologues of both proteins was found to be
mutually exclusive in early stages of embryogenesis
(24,27). Still, it remains to be assessed the relevance of
MEX3A in multiple pathological contexts of the gastro-
intestinal tract where differentiation abnormalities
directed by CDX2 are key events.
In conclusion, we have identiﬁed a novel role for
MEX3A protein in the regulation of intestinal differenti-
ation, polarity and stemness features, partially mediated
by the repression of CDX2. This is the ﬁrst description of
a CDX2 regulatory mechanism based on its mRNA
control by an RBP, having a signiﬁcant impact in
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intestinal homeostasis and likely in gastrointestinal
carcinogenesis.
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